Preview

Advances in Molecular Oncology

Advanced search
Fullscreen

For citations:


Yurova M.N., Safina D.R., Mizgirev I.V. SELECTIVE INHIBITION OF KRAS SIGNALING BY COMBINATION OF LOW DOSE RAPAMYCIN AND PACLITAXEL IN VIVO. Advances in Molecular Oncology. 2018;5(2):42-49. (In Russ.) https://doi.org/10.17650/2313-805X-2018-5-2-42-49



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2313-805X (Print)
ISSN 2413-3787 (Online)